Home/Nucleome Therapeutics/James Heward

JH

James Heward

Vice President, Functional Genomics

Nucleome Therapeutics

Therapeutic Areas

Immune-mediated Inflammatory Diseases

Leadership Team at Nucleome Therapeutics

Chief Executive Officer

Dr. Michelle Morrow

Chief Scientific Officer

Chief Technology Officer

View full Nucleome Therapeutics profile